PHYSICIAN REWARDS FOR POSTMARKETING SURVEILLANCE (SEEDING STUDIES) IN THE US

被引:2
作者
LAPUMA, J [1 ]
机构
[1] UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637
关键词
D O I
10.2165/00019053-199507030-00001
中图分类号
F [经济];
学科分类号
02 ;
摘要
[No abstract available]
引用
收藏
页码:187 / 190
页数:4
相关论文
共 12 条
[1]  
La Puma J., Stocking C.B., Rhoades W.J., Et al., Should disclosure of physician remuneration be part of informed consent to research, Clin Res, 41, 2, (1993)
[2]  
La Puma J., Kraut J., How much do you get paid if I volunteer, Hosp Health Services Admin, 39, 2, pp. 193-203, (1994)
[3]  
Milner L.S., Ethical considerations in clinical cancer research: the need for disclosure of financial compensation, J Oncol Manage, 2, 3, pp. 36-41, (1993)
[4]  
Moore V., Regents of University of California, 51 Cal 3rd 120, 793 P.2d 479,271 Cal Reptr 147, Supreme Court of California, (1990)
[5]  
Guidelines on postmarketing surveillance, BMJ, 296, pp. 399-400, (1988)
[6]  
Shimm D.S., Spece R.G., Conflict of interest and informed consent in industry–sponsored clinical trials, J Legal Med, 12, pp. 477-513, (1991)
[7]  
Leyine R.J., Ethics and the regulation of clinical research, 2nd ed, New Haven, CT: Yale University Press, (1988)
[8]  
Spiro H.M., Mammon and medicine: the rewards of clinical trials, JAMA, 255, (1986)
[9]  
Stephens M.D.B., Marketing aspects of company–sponsord postmarketing surveillance studies, Drug Saf, 8, 1, pp. 1-8, (1993)
[10]  
Shimm D.S., Spece R.G., Ethical issues and clinical trials, Drugs, 46, 4, (1993)